Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients.

NCT02971696 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

HCC

Interventions

DRUG: Sorafenib
DRUG: Best Supportive care

Sponsor

Ain Shams University